Arla Foods Ingredients: Pioneering Dairy Innovation

Company Overview: Arla Foods Ingredients (AFI) is a leading force in the dairy-derived ingredients sector. With its headquarters in Viby, Denmark, AFI has established itself as a pioneer in developing innovative food ingredients and maintains a strong global presence.

Facilities and Operations

AFI operates an advanced production facility in Videbæk, Denmark, known for its cutting-edge capabilities in producing dairy ingredients. The company also has an Innovation Center in Aarhus, Denmark, dedicated to research and development focused on creating groundbreaking food ingredients.

Leadership

Under the leadership of CEO Henrik Andersen, Arla Foods Ingredients has experienced significant growth and innovation. Andersen's strategic vision has been critical in advancing the company within the dairy industry.

Financial Indicators

Arla Foods Ingredients reported revenues exceeding EUR 800 million, contributing approximately 10% to the total revenue of the Arla Foods Group. The increasing global demand for premium dairy ingredients has significantly bolstered the company's profitability.

Important Company Events

2019: Expanded operational capacity with a new lactose manufacturing site in Nr. Vium, Denmark.
2021: Launched its first organic micellar casein isolate, meeting the demand for organic nutrition products.
2022: Introduced Nutrilac® FO-7875, an innovative infant formula ingredient designed to reduce costs while maintaining high nutritional standards.
Recently acquired Volac’s Whey Nutrition business, further strengthening its market leadership.

Company Plans

Arla Foods Ingredients is pursuing an ambitious growth strategy, including expanding production capabilities in Asia and the Americas, and investing in R&D for products targeting sports, infant, and medical nutrition. The company is committed to enhancing sustainability by reducing carbon emissions and increasing energy efficiency. Furthermore, AFI is adapting to new regulatory changes allowing the declaration of milk fat globule membrane (MFGM) on products across the EU, showcasing its dedication to quality and innovation.

The company has introduced Whey360, emphasizing MFGM benefits following EU approval, and has extended its distribution partnership with the Brenntag Group to Southeast Asia. Additionally, AFI is expanding into the performance nutrition market in ANZ/Oceania through a new distribution partnership with Alchemy Agencies. This partnership aims to serve the performance nutrition market in Australia, New Zealand, and the Pacific Islands, featuring five main brands from AFI's premium range: Lacprodan whey protein isolate, Capolac, MicelPure, Nutrilac PB-8420, and Nutrilac MFGM. Arla Foods Ingredients has extended its distribution partnership with MasterSense for the Chilean market, focusing on the performance nutrition and food and beverage segments.

Modified: 2025/05/18